john r. floyd, ii m.d. franco demonte, m.d. ut, md anderson cancer center ut, health science center...

38
JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma Classification Paradigm

Upload: andrea-greer

Post on 18-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

JOHN R. FLOYD, II M.D.FRANCO DEMONTE, M.D.

U T, M D A N D E R SO N C A N C E R C E N T E R U T, H E A LT H S C I E N C E C E N T E R SA N A N T O N I O

Hyperostosing Spheno-Orbital Meningioma Classification Paradigm

Page 2: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

en plaque meningiomas with carpet like growth patterns,

osseous invasion, and hyperostosis.

global meningiomas grow into the Sylvian fissure, and

its diameter is typically greater than the base.

Cushing, H. and L. Eisenhardt, Meningiomas. Their classificaion, regional behavior, life history, and surgical end results. 1938, Springfield, IL:

Charles C. Thomas.

Page 3: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Incidence

Castellano (1952) reviewed 608 cases of meningiomas

111 (18.4%) were along the sphenoid ridge

15 (2.5%) were associated with hyperostosis

Incidence varies from 4-9% in case series

Castellano, F., B. Guidetti, and H. Olivecrona, Pterional meningiomas en plaque. J Neurosurg, 1952. 9(2): p.

188-96

Page 4: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

1950’s….conservative

“It is true that vision on the affected side may be severely impaired or entirely lost….Nevertheless….this hardly seems to be sufficient reason to run the risk of a 10-15% mortality”

“ The bone must be burred away, which is a rather dangerous procedure, as the fraise (burr) might slip. In one of our cases, this happened and the carotid artery was torn completely off at its point of entrance into the cranial chamber. This patient died two days later from the effects of cerebral ischaemia.

Castellano, F., B. Guidetti, and H. Olivecrona, Pterional meningiomas en plaque. J Neurosurg, 1952. 9(2): p. 188-96.

Page 5: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Group Type Location Extension

A en masse Clinoid, Cavernous

Sinus, Medial

Sphenoid wing

Upward or

Medial

B en plaque Greater and Lesser Sphenoid

Wings

Downward

C en masse Combines feature of each

Bonnal, J., et al., Invading meningiomas of the sphenoid ridge. J Neurosurg, 1980. 53(5): p. 587-99.

Page 6: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Roser, F., et al., Sphenoid wing meningiomas with osseous involvement. Surg Neurol, 2005. 64(1): p. 37-43; discussion 43.

Group

Location Extension

IMedial Sphenoid

WingNone

IIMedial Sphenoid

WingCavernous

Sinus

IIIMiddle Sphenoid

WingNone

IVLateral Sphenoid

WingNone

V En plaque None

VI En PlaqueCavernous

Sinus

VIIPure

IntraosseousNone

Page 7: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Confusing Nomenclature

1. En masse2. En plaque3. Sphenoid ridge meningiomas4. Pterional tumors en plaque5. Hyperostosing lesions of the ala magna6. Invading meningiomas of the sphenoid wing7. Spheno-cavernous meningiomas8. Intraosseous meningiomas9. Osteomeningioma10. Extradural meningiomas11. Spheno-Orbital Meningiomas

Page 8: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Author Yr Patients Mortality Perm Morbidity

Temp Morbidity

Recurrence

1 Castellano, F 1952 15 3 (23%)

2 Columella, F 1974 3 0 (0) 0 (0) 0 (0) NS

3 Bonnal, J 1980 21 4 (19%) 12 (41%) --- 3 (10%)

4 Dolenc, V 1979 10 2 (20%) 2 (20%)

5 Pompili, A 1982 49 2 (4 %) 1 (2%) 13 (27%)

6 McDermott, M 1990 8 0 ( 0 ) 2 ( 25%) 8 (100%)

7 Gaillard, S 1995 21 1 (5%) --- 9 (43%) 3 (14%)

8 Carrizo, A 1998 48 2 (4%) 7 (15%) 11 (23%) 8 (17%)

9 De Jesus, O 2001 6 NS NS NS 2 (33%)

10 Honeybul, S 2001 15 0 (0) 4 (27%) 11 (73%) 2 (13%)

11 Roser, F1 2005 82 1 (1.4 %) 7 (9%) 11 (13%) 25 (30%)

12 Sandalcioglu, E 2005 16 0 ( 0 ) 2 (13%) 12 (80%) 9 ( 60%)

13 Schick, U 2006 67 0 (0) 9 (13%) 14 (21%) 7 ( 10%)

14 Ringel, F 2007 63 2 (3.2%) 21 (33%) 23 (37%) 16 (25%)

15 Al_Mefty, O 2007 17 0 (0) 0 (0) 4 (24%)

Page 9: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

1. Multiple classification schemes.

2. Confusing nomenclature.

3. Currently, there are no Preoperative Classification schemes

Rationale

Page 10: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Purpose of the Preoperative Scale

allows the surgeon to carefully evaluate the surgical condition,

to determine risk factors for and against a procedure,

to anticipate outcomes and problems in the postoperative period,

to educate patients

Page 11: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Proposed Classification Scheme

1. Osseous invasion

2. Soft tissue invasion

3. Presence of cranial nerve neuropathy

Page 12: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Osseous InvasionSphenoid Bone: Posterior Superior View

Osseous Score Anterolateral greater sphenoid wingLesser sphenoid wingLateral orbital wall Orbital roof Lateral or superior orbital rimTemporal squamousal bone Temporal mandibular joint

1

Inferomedial greater sphenoid wing• medial to basal foramina

Anterior clinoid process/optic canal2

Body of sphenoid bone 3

Page 13: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Anteriolateral and inferiomedial greater wing of sphenoid affected; body of sphenoid, lesser wing, and anterior clinoid are not involved.

Osseous Invasion

Page 14: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Soft Tissue Invasion

Soft Tissue ScoreTemporalis muscle / fossaInfratemporal fossaTemporal convexity duragloboid intradural component Intraorbital extraperiorbitalPeriorbital membraneIntraperiorbital extraconal

1

Dura of lateral cavernous sinusDura of the superior orbital fissureIntraperiorbital intraconal extra-apicalOptic canal

2

cavernous sinusIntraperiorbital, intraconal, orbital apexSuperior orbital fissure

3

Page 15: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Soft Tissue Invasion

Lateral temporal dura and small intradural component.

Page 16: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Soft Tissue Invasion

Lateral cavernous sinus, superior orbital fissure, orbital apex

Page 17: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Cranial Nerve Neuropathy

Optic NeuropathyNone 0Mild Optic Neuropathy Relative afferent papillary defect Decreased color vision Acuity better or equal to 20/400 Mild optic nerve pallor Visual field deficit

1

Moderate Optic Neuropathy Acuity worse that 20/400 Optic nerve atrophy

2Severe Optic Neuropathy Light perception only 3Cranial III, IV or VI palsyAbsent APresent B

Page 18: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Score Grade

2-3 I

4-6 II

7-9 III

Proposed Scale for Hyperostosing Spheno-Orbital Meningiomas (HSOMs)

Page 19: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Patients were identified from the Departmental database from February 1994 until April 2008.

All meningiomas of the sphenoid ridge, cavernous sinus, and orbit were included if there was associated hyperostosis.

Patients 20

Male 4 (20%)

Female 16 (80%)

Ages 31-83 (yrs)

Mean Age 54 (yrs)

Mean Follow-up 41 (mos)

Previous Surgery 5 (25%)

Perioperative Deaths 0Deaths During Follow-up 2 (10%)

Recurrences 5 (25%)Mean time to recurrence 32 (mos)

Demographics

Page 20: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Presenting Signs & Symptoms N=20   %

Proptosis 18 90%

Vision loss 12 60%

Diplopia 9 45%

Temporal Swelling 4 20%

Aphasia 3 18%

CN Palsy 4 20%

Presenting Symptoms

Page 21: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

MethodsPatients had formal

ophthalmological evaluations pre and postop.

Patients had detailed neuro-imaging including CT scan, MRI brain =/- Gad with orbital fat sat sequences.

Bicoronal incision, extradural approach was utilized, with orbital and zygomatic osteotomies as needed.

Page 22: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Preoperative Score

Preoperative Criteria and Accumulated Score

Patient #

Bone Score

Soft Tissue Score

Optic neuropathy

Cranial n. III, IV, VI

ScoreTotal Score

Pre- operative Grade

3 2 1   A 3 IA15 2 1   A 3 IA16 2 1   A 3 IA20 1 1 A 2 IA1 2 1 1 A 4 IIA2 3 2   A 5 IIA5 2 2   A 4 IIA6 2 3   A 5 IIA8 2 3 1 A 6 IIA9 2 1 1 A 4 IIA

10 2 3 1 A 6 IIA11 2 3 1 A 6 IIA13 1 3 2 A 6 IIA14 2 3   A 5 IIA17 1 3 1 A 5 IIA4 1 2 1 A 4 IIA7 1 3 1 B 5 IIB

18 2 3 1 B 6 IIB12 1 3 3 B 7 IIIB19 3 3 3 B 9 IIIB

Page 23: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Outcomes Evaluated

1. Clinical Outcomesa. Proptosisb. Visionc. Diplopia

2. Technical Outcomesa. Extent of Resection ( Simpson Grade)

3. Oncologic Outcomea. Time to Progression

Page 24: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Clinical Outcomes: Proptosis

1. Roser, F., et al., Sphenoid wing meningiomas with osseous involvement. Surg Neurol, 2005. 64(1): p. 37-43; discussion 43.

2. Shrivastava, R.K., et al., Sphenoorbital meningiomas: surgical limitations and lessons learned in their long-term management. J Neurosurg, 2005. 103(3): p. 491-7.

3. Bikmaz, K., R. Mrak, and O. Al-Mefty, Management of bone-invasive, hyperostotic sphenoid wing meningiomas. J Neurosurg, 2007. 107(5): p. 905-12.

4. Honeybul, S., et al., Sphenoid wing meningioma en plaque: a clinical review. Acta Neurochir (Wien), 2001. 143(8): p. 749-57; discussion 758.

5. Ringel, F., C. Cedzich, and J. Schramm, Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery, 2007. 60(4 Suppl 2): p. 214-21; discussion 221-2.

6. Sandalcioglu, I.E., et al., Spheno-orbital meningiomas: interdisciplinary surgical approach, resectability and long-term results. J Craniomaxillofac Surg, 2005. 33(4): p. 260-6.

7. Schick, U., et al., Management of meningiomas en plaque of the sphenoid wing. J Neurosurg, 2006. 104(2): p. 208-14.

Symptom Preop Postop

Proptosis Improved Worsened New Morbidity

18 15 (83%) 0 0

233* 185 (79%) 0 5 (2%)

(enopthalmus)

Page 25: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Proptosis

No statistical trend across preoperative grades, eg, Grade IA vs Grade IIIB.

The bone score as an independent variable did not predict the Simpson Grade of resection or recurrence/progression.

Page 26: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Clinical Outcomes: Vision

Optic Neuropathy Postoperative Improvement    

Preoperative

# Patients APD CD ECF*< or + 20/400

LPO

APD 12 0  CD 6   1  ECF 4   2   *< or = 20/400 4   3  LPO 2   0

             

Symptom Preop Postop Vision

Improved Worsened New Morbidity12 4 (42%) 0 0

133* 58 (43%) 3 (2%) 1 (< 1%)

APD =Afferent Pupillary Defect; CD = Color Desaturation; ECF = Enlarged Central Field; * Acuity; LPO = Light Perception Only

Page 27: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Clinical Outcomes: Vision

Positive trend toward absence of Optic Neuropathy (ON) and Simpson Grade I resection and Preoperative Grade IA. (not statistically significant).

Positive trend (p=0.074) toward the presence of ON and Simpson Grade IV resection (not statistically significant).

Presence of Optice Neuropathy as an independent variable did not predict the Simpson Grade of resection or progression or recurrence

Page 28: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Clinical Outcomes: Diplopia

4/9 (44%) patients diplopia resolved Double vision caused from rectus muscle constriction. Orbital decompression relieved symptoms.

• 5/9 (55%) patients had unchanged diplopia 4 were due to true CN III, IV or VI palsy 1 pt had previous TBI

• 1 patient developed delayed double vision due to lateral rectus fibosis

Page 29: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Diplopia

• Positive trend for the absence of CN palsy in the preoperative Grade IA HSOMs (not statistically

significant).

• The presence of cranial nerve palsy did not independently predict the Simpson Grade of resection, progression or recurrence.

Page 30: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Clinical Outcomes

Summary of Clinical OutcomesClinical Outcome: Improved (I); Stable (S), Worse (W)

Grade Patient # Proptosis ON Diplopia

IA

3 I  15 I  16 I I20 I  

IIA

1   I  2 I I5  6 I I8 I S  9 I I  

10 I S  11 I I  13 I I I14 I  17 S S S4 I I W

IIB 7 I S S18 S S  

IIIB 12 S S S19 S S S

Page 31: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Technical and Oncological Outcomes

Technical OutcomeOncologic Outcome

Preoperative Grade HSOM

Patient # Simpson Grade

(extent of resection)

Time to Progression

(Months)

IA

3 I  15 I  16 I  20 I  

IIA

1 I  2 I  5 I  6 IV 98 IV 969 IV  10 IV 2411 IV 1813 IV 1214 IV  17 IV  4 I  

IIB 7 IV  18 IV  

IIIB 12 II 1219 IV  

Page 32: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Technical and Oncological Outcomes

Series Yr Followup average (mos)

# Pts Recurrence (%)

Time to Recurrence (mos)

Average Time to Recurrence (mos)

 

Honeybul, S 2001 40 15 2 (13%) 36,96 66  

Roser, F 2005 66 82 25 (30%) Not specified 32  

Sandalcioglu, E 2005 68 16 9 ( 60%) 16,118,13,66,47,62,9,12, 17

40

 

Shrivastava, R 2005 60 25 2 (8%) 12, 132 73  

Schick, U 2006 46 67 7 ( 10%) 29,21,47,21,14,23,13

24  

Ringel, F 2007 54 63 16 (25%) Not Specified Not Specified  

Bikmaz, K. 2007 36 17 1 (6%) 72 72  

DeMonte 2009 42 20 5 (25%) 96,24,18,12,9 32 

Page 33: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Technical and Oncological Outcomes

Positive trend toward HSOM Grade IA and Simpson Grade I with no recurrences (not statistically significant).

The individual bone score, presence or degree of optic neuropathy, presence or absence of cranial nerve palsy did not predict Simpson Grade resection, progression, or recurrence

Soft tissue score was highly predictive of Simpson Grade resection ( p<0.001)

When grouping soft tissue score 1 +2 vs. 3, this did predict tumor progression. ( p <0.045)

When analyzed as a continuous variable, the hazard score for the total score ( eg 2-9; not by Grade), is 3.7,

95% CI 0.95 – 14.4, with a p value close to significance p = 0.06

Page 34: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Oncologic Outcomes

Areas of progression: cavernous sinus (two), orbital apex and cavernous sinus (two), and intraorbital (one).

All patients have had tumor stabilization with either: SRS IMRT

Page 35: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Other Variables

No statistical difference between preoperative score or grade and:

Gender Histological grade MIB rate

Progression was unrelated to MIB rate or histology

Positive trend between higher preoperative grade and increasing age (not statistically significant).

Page 36: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Conclusions

Overall, proptosis will improve 80% of time

Vision will improve about 40% of time ( no improvement if LPO)

Cranial nerve III,IV, or VI palsy tend not to improve

The strongest correlation with predicting outcomes is the soft tissue score: Extent of resection ( Simpson Grade) Risk for Progression Progression occurs from residual tumor in

the cavernous sinus, superior orbital fissure, orbital apex

Limitations Limited

number of patients

Short follow-up for certain patients

Page 37: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

Conclusions

Trends Grade IA:

Improved Clinical Symptoms Complete Resections No recurrences

Grade IIA: Improved or Stabilized Clinical

Symptoms Incomplete Resections More likely to have

recurrence/progression Grade IIB or IIIB

Stabilized Clinical Symptoms Incomplete Resections More likely to have

recurrence/progression

Page 38: JOHN R. FLOYD, II M.D. FRANCO DEMONTE, M.D. UT, MD ANDERSON CANCER CENTER UT, HEALTH SCIENCE CENTER SAN ANTONIO Hyperostosing Spheno-Orbital Meningioma

SummaryThe approach to HSOMs has

shifted

from a nonsurgical stance, to a present day patient

outcome oriented strategy.